Betty Mwesigwa

Assessment of tuberculosis disease activity in people infected with Mycobacterium tuberculosis and living with HIV: A longitudinal cohort study

M. Hoelscher, A. Esber, L. Eller, 2022, EClinicalMedicine.

Developing capacity for implementation and evaluation of vaccine trials in Uganda: Perspective of the Makerere University Walter Reed Project

F. Wabwire-mangen, H. Kibuuka, J. Ssensamba, 2022, African health sciences.

Vaccine Licensure in the Absence of Human Efficacy Data

R. Rustomjee, E. Leffel, Courtney L. Finch, 2022, Vaccines.

1049. Minimal Transient HIV-1 Viremia Following Vaccination Regimens Containing AD26. ZEBOV and MVA-BN-Filo in ART-Suppressed People Living with HIV

L. Jagodzinski, A. Esber, I. Jani, 2021, Open Forum Infectious Diseases.

Predictors of All-Cause Mortality Among People With Human Immunodeficiency Virus (HIV) in a Prospective Cohort Study in East Africa and Nigeria

A. Esber, H. Kibuuka, T. Crowell, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV-1 Remission: Accelerating the Path to Permanent HIV-1 Silencing

S. Gianella, L. Ndhlovu, N. Roan, 2023, Viruses.

Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial.

J. Mascola, R. Koup, C. Andrews, 2023, The Lancet. Infectious diseases.